drugset / Trial / NCT06964776
A Study of LY4268989 (MORF-057) in Healthy Participants
RandomizedParallel-groupDouble-blindBasic science
Summary
The purpose of this study is to measure the body's absorption and processing of the study drug, the study drug's effect on the body, safety, and tolerability with LY4268989 (MORF-57) in healthy participants, including Japanese and Chinese participants
Timeline
- Start
- 2025-05-01
- Primary completion
- 2026-02-17
- Completion
- 2026-02-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY4268989 | Unknown | — | Oral |
| Subject | Midazolam | Small molecule | — | Oral |
Indications
No indication recorded.